Colonoscopy Every Three Years Indicated For Those With Family History Of Polyps
Men With Low PSA Scores May Not Need Annual Tests, Data From PLCO Trial Suggests
Gleevec Better Than Interferon For Newly Diagnosed CML
Two-Drug Combination Extends Survival Of Mesothelioma
Preventive Surgery Cuts Risk Of Breast, Ovarian Cancers
Two-Month Survival Benefit For Some NSCLC Patients
Cancer Cases To Double By 2050, Annual Report Says
Women Radiated For Wilms’ At Risk For Complications In Pregnancy, Study Finds
St. John’s Wort Not Indicated For Patients On Irinotecan
Large Pregnancy Weight Gain Raises Risk For Breast Cancer
Clinical Trials Approved Last Month By NCI’s CTEP
Trending Stories
- How George Tidmarsh crossed the FDA-industry Rubicon
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA
- Class action complaint alleging GRAIL insider fraud resubmitted after dismissal
- CDER Director Tidmarsh quits amid inspector general probe of his “personal conduct”
Cancer advocates express concern about comments that signal trouble for accelerated approval - City of Hope’s leadership in lung cancer: Precision, innovation, and a vision for cure
- How GLP-1RA drugs are reshaping patient physiology and the future of oncology









